Is Better Patient Knowledge Associated with Different Treatment Preferences? A Survey of Patients with Stable

Neal Yuan1, Christy Boscardin2, Nadra E Lisha2

  • 1Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Insights

Improving shared decision-making in coronary artery disease (CAD) requires more than patient education. Patient knowledge about percutaneous coronary intervention (PCI) did not influence treatment preferences, while race did. Patient preferences were also not consistently reflected in treatment decisions.

Area of Science:

  • Cardiology
  • Health Services Research
  • Patient-Centered Care

Background:

  • Shared decision-making (SDM) is recommended for stable coronary artery disease (CAD) patients deciding between percutaneous coronary intervention (PCI) and medical therapy due to similar outcomes.
  • The impact of enhanced patient-provider communication and knowledge on patient preferences and treatment choices in stable CAD remains unclear.

Purpose of the Study:

  • To explore the relationships between patient-provider communication, patient knowledge, patient preferences, and the actual treatment received in stable CAD patients.
  • To determine if improving patient knowledge through communication influences treatment preferences and decisions.

Main Methods:

  • A survey of 87 stable CAD patients referred for elective cardiac catheterization was conducted.
  • Surveys assessed patient-provider communication, medical knowledge, and treatment preferences; treatment received was verified via chart review.
  • Linear and logistic regression analyses examined the associations between communication, knowledge, preference, and treatment received.

Main Results:

  • Increased discussion of PCI and medical therapy benefits/risks correlated with higher patient knowledge scores (β=0.28, p<0.01).
  • Patient knowledge did not significantly influence preference for PCI (OR=0.78, p=0.09).
  • Black patients were over four times more likely to prefer medical therapy over PCI (OR=4.49, p=0.03), and patient preferences did not significantly predict PCI receipt (OR=0.67, p=0.57).

Conclusions:

  • Enhanced communication may improve patient knowledge but not necessarily alter treatment preferences in stable CAD.
  • Patient background factors, such as race, appear more influential on treatment preferences than medical knowledge.
  • Current shared decision-making practices may not adequately incorporate patient preferences, necessitating a deeper understanding of patient backgrounds and beliefs.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
95
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
123
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
154
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
113